Sign Out
Hypersensitivity to the active substance or to any of the excipients in the formula.
Severe hepatic impairment.
Active pathological bleeding such as peptic ulcer or intracranial haemorrhage.
The concomitant use of this product and repaglinide is contraindicated.
